Literature DB >> 163071

Glomus tumors in the head and neck: III. Analysis of clinical manifestations.

G J Spector, R H Ciralsky, J H Ogura.   

Abstract

Seventy-five patients with glomus tumors in the head and neck had a 37% incidence of cranial nerve paralysis and a 14.6% incidence of intracranial extension. Jugular foramen syndrome is associated with 50% and hypoglossal nerve involvement with 75% posterior fossa tumor invasion. Horner's syndrome is associated with 50% middle cranial fossa tumor invasion. The incidence of central nervous system (CNS) involvement with cranial NERVE PARALYSIS (NOT INCLUDING VII nerve) is 52%. Otologic findings and VII nerve paralysis did not correlate with tumor resectability, CNS extension, and prognosis.

Entities:  

Mesh:

Year:  1975        PMID: 163071     DOI: 10.1177/000348947508400111

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  6 in total

1.  Endovascular treatment of pulsatile tinnitus caused by dural sinus stenosis.

Authors:  J M Mathis; D Mattox; P Malloy; G Zoarski
Journal:  Skull Base Surg       Date:  1997

2.  An update on the surgical treatment of temporal bone paraganglioma.

Authors:  K S Moe; D Li; T E Linder; S Schmid; U Fisch
Journal:  Skull Base Surg       Date:  1999

3.  Pulsatile tinnitus--a review of 84 patients.

Authors:  D Waldvogel; H P Mattle; M Sturzenegger; G Schroth
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

4.  Rare glomangiosarcoma of the tongue.

Authors:  Sumetha Rajendran; Arthur Harry Henderson; Stuart Gillett
Journal:  BMJ Case Rep       Date:  2018-07-03

5.  A Rare Case of Glomus Tumor on the Mucosal Surface of Lower Lip.

Authors:  Sara Naji Rad; Samira Najirad; Rana Rafiei
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

6.  Hsa_circ_0008309 May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.

Authors:  Bowen Li; Feng Wang; Xiang Li; Shuai Sun; Yuehong Shen; Hongyu Yang
Journal:  Dis Markers       Date:  2018-09-23       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.